Abstract

Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers of non-alcoholic steatohepatitis: A systematic review and meta-analysis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani ... Michael Charlton
Hepatology | VOL. 55
Naga Chalasani, et. al.Naga Chalasani ... Michael Charlton
29 May 2012
Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitis.
Petra Hirsova ... Gregory J. Gores
Hepatology | VOL. 61
Petra Hirsova, et. al.Petra Hirsova ... Gregory J. Gores
20 Nov 2014
Nonalcoholic Fatty Liver Disease and Fibrosis Progression: The Good, the Bad, and the Unknown
Stephen A Harrison
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | VOL. 13
Stephen A HarrisonStephen A Harrison
03 Dec 2014
A Revisit of the Natural History of Nonalcoholic Fatty Liver Disease
Mazen Noureddin ... Vincent Wai-Sun Wong
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | VOL. 21
Mazen Noureddin, et. al.Mazen Noureddin ... Vincent Wai-Sun Wong
27 Aug 2022
View more papers

More From: Diabetes, Obesity and Metabolism

Paper Title
Journal
Date
Author
Higher early pregnancy plasma myo-inositol associates with increased postprandial glycaemia later in pregnancy: Secondary analyses of the NiPPeR randomized controlled trial.
Han Zhang ... Wayne S Cutfield
Diabetes, Obesity and Metabolism | VOL. 26
Han Zhang, et. al.Han Zhang ... Wayne S Cutfield
05 Feb 2024
Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?
Osagie Ebekozien ... Ashutosh Sabharwal
Diabetes, Obesity and Metabolism | VOL. Suppl 26 1
Osagie Ebekozien, et. al.Osagie Ebekozien ... Ashutosh Sabharwal
31 Jan 2024
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD.
Thomas Eissing ... Dirk Garmann
Diabetes, Obesity and Metabolism | VOL. 26
Thomas Eissing, et. al.Thomas Eissing ... Dirk Garmann
30 Nov 2023
Effect of the dual sodium-glucose co-transporter-1 and -2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Maria Anna Bantounou ... Panagiotis Sardellis
Diabetes, Obesity and Metabolism | VOL. 26
Maria Anna Bantounou, et. al.Maria Anna Bantounou ... Panagiotis Sardellis
29 Nov 2023
View more papers